Rights Offering Final Price Set at 4,860 Won


  • Final issue price set at 4,860 won for 16,830,200 new common shares.
  • The final price is the lower of the 1st issue price (6,260 won) and 2nd issue price (4,860 won).
  • Finalization date: 2026-05-08, disclosure on 2026-05-11.
  • Rights offering followed by public offering for unsubscribed shares; dilution risk for existing shareholders.
ADVERTISEMENT (250px+)

KOSDAQ Filing Information


  • Filing: Determination of Final Issuance Price for Rights Offering
  • Company: ImmuneOncia Therapeutics (424870)
  • Submission: ImmuneOncia Therapeutics, Inc.
  • Receipt: 05-08-2026
  • Under KRX KOSDAQ Market Division